A new national study has raised concerns about the heart health of colorectal cancer (CRC) survivors, showing that sudden cardiac death (SCD) is still a serious risk that is often overlooked, even with major improvements in cancer treatment. The study, conducted by Eric Sanji of Magnolia Regional Health Centre and published on November 7, 2025, in Volume 12 of Oncoscience, demonstrates that, while overall SCD rates have decreased over the last two decades, significant differences continue across sex, race, and region.

Colorectal cancer is one of the world's major causes of cancer-related death. Thousands of people have had their lives extended thanks to improved detection and treatments. However, survival presents new problems. Many survivors face long-term hazards that go well beyond the cancer. Cancer therapies can harm the heart, and elderly survivors often face additional cardiac vulnerabilities, making heart-related issues a major concern. 

The researchers used the CDC WONDER Multiple Cause of Mortality database to analyse mortality records from 1999 to 2020 in the United States, mapping SCD patterns by age, race, gender, and state. They pointed out, "Colorectal cancer (CRC) fatalities were identified using ICD-10 codes C18-C21, and sudden cardiac death (SCD) was defined using ICD-10 codes I46.1, I46.9, R96.0, I49.0, and I21-I24." These codes are particular medical classifications for cancer and heart-related causes of death. 

The data show that the age-adjusted SCD death rate among CRC patients has decreased from 1.2 per 100,000 individuals in 1999 to 0.5 by 2020. This is a significant accomplishment, showing improved cancer management and overall heart disease prevention. However, the benefits are distributed unevenly. Black and Asian/Pacific Islander patients had consistently higher SCD mortality rates than white patients. Men were also at higher risk than women, highlighting the necessity of gender-sensitive public health planning. 

Geography exacerbated the difference. States with higher per capita SCD deaths included Nebraska and Vermont, whereas more populous states like California and Texas exhibited lower rates. The greatest burden fell on patients aged 65 to 84, who were already more vulnerable due to ageing, several chronic conditions, and the cardiotoxic effects of chemotherapy or radiation. Simply put, several cancer treatments can disrupt the heart's electrical system, increasing the risk of harmful cardiac rhythms. 

The study emphasises a larger public-health issue: disparities in access to monitoring, follow-up care, and preventative interventions. Socioeconomic hurdles, healthcare disparities, and structural imbalances all contribute to the ongoing risk. The authors stress the importance of improved cardio-oncology services—specialised care that brings cancer and heart specialists together—to ensure the early detection and management of cardiac problems. 

As CRC survival rates increase, preserving the heart becomes as important as treating the cancer. For ageing populations, women whose symptoms are frequently disregarded, and racial groups with higher vulnerability, prompt and equitable cardiac monitoring could avert unnecessary deaths.